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Abstract
Early linkage to care and engagement in care are critical for initiation of medical interventions.
However, over 50% of newly diagnosed persons do not receive HIV-related care within 6 months
of diagnosis. We evaluated a linkage to care and engagement in care initiative for HIV-positive
adolescents in 15 U.S.-based clinics. Structural and client-level factors (e.g. demographic and
behavioral characteristics, clinic staff and location) were evaluated as predictors of successful
linkage and engagement. Within 32 months, 1172/1679 (69.8%) of adolescents were linked to care
of which 1043/1172 (89%) were engaged in care. Only 62.1% (1043/1679) of adolescents were
linked and engaged in care. Linkage to care failure was attributed to adolescent, provider, and
clinic-specific factors. Many adolescents provided incomplete data during the linkage process or
failed to attend appointments, both associated with failure to linkage to care. Additional
improvements in HIV care will require creative approaches to coordinated data sharing, as well as
continued outreach services to support newly diagnosed adolescents.
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INTRODUCTION
Linkage to care (LTC) refers to the process of initiating HIV-related medical, psychological
and social services for newly diagnosed HIV-positive persons. (1) Failures in linkage are
associated with lower levels of viral suppression, and greater likelihood of viral resistance.
(2, 3) In the United States, only about 28% of HIV-positive individuals achieve viral
suppression, in part due to LTC failures. (4, 5) Interventions focused on case-management
and structural issues have improved LTC rates among newly diagnosed HIV-positive adults
but these interventions have not included adolescents.(6-8)
Engagement in care refers to the maintenance of HIV-related health care following initial
linkage. (9) The process of engagement requires – at minimum – adherence to scheduled
clinic visits (usually at defined 3-6 months intervals).(10) Although up to 90% of recently
diagnosed individuals complete a second HIV-related visit after linkage, only 45%-55%
complete at least one visit every 6 months (11, 12). Engagement is associated with improved
clinical status and reduced mortality, (1, 9, 13, 14) and increases the likelihood of viral load
suppression, which is an important secondary HIV transmission prevention strategy. (12)
Approximately 60% of HIV-positive 13-24 year olds are undiagnosed, supporting the
importance of expanded testing efforts in this age group.(15),(16) However, increased
testing creates a need for HIV-related health services, few of which are specifically designed
for adolescents. (17) Adolescents delay linkage for longer periods and are less likely to link
to care compared to older adults. (12, 18-21) For adolescents linked to care, engagement is
relatively high, with up to 83% in care for up to a year following initial linkage. (22)
However, adolescents in treatment fail about one-third of scheduled visits, and
approximately 30% of adolescents drop out of care after being engaged. (18) Adolescents
have lower rates of viral suppression, and higher rates of virologic rebound compared to
adults.(23)
Care linkage and engagement represent a continuum of needed services that likely differ in
terms of client and provider characteristics.(6, 24, 25) Yet almost no information exists to
guide program and service planning to engage newly diagnosed adolescents in a “seamless”
continuum of HIV-related care, as emphasized in the U.S. National HIV/AIDS Strategy.(26)
Here, we present national-level data on HIV care linkage and engagement for HIV-positive
adolescents.
METHODS
Data were collected from 15 Adolescent Medicine Trials Network for HIV/AIDS
Interventions clinic sites. These clinics, known as Adolescent Medicine Trial Units
(AMTU), care for adolescents, ages 12-24, in 13 cities across the U.S. and Puerto Rico.
Each AMTU implemented the Care Initiative in 2010. This initiative is a collaborative effort
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of the National Institute for Child Health & Human Development, the Centers for Disease
Control & Prevention, and the Adolescent Trials Network. The care initiative facilitated
formal relationships among the AMTU, local health departments, and local youth-serving
organizations involved with HIV testing and treatment.(27) Memoranda of understanding
between AMTU and local health departments specifically addressed the provision of public
health authority (PHA) to the AMTU. Sites receiving PHA could directly contact newly
diagnosed adolescents to arrange linage. Each AMTU employed a trained outreach worker
(OW) to contact youth, arrange HIV care, and obtain de-identified client data. Each local
Institutional Review Board reviewed and approved all procedures.
Clinic and provider measures
Two categories of independent measures were client-level and clinic/provider-level factors.
Client-level factors were derived from data recorded by the OW and included age, gender,
self-reported race/ethnicity, education, sexual identity, homeless status, health insurance
status, mode of HIV acquisition, lifetime history of syphilis, marijuana use in the past 12
months, and other drug use.
Clinic/provider-level factors were largely derived from AMTU-reported data, memoranda of
understanding between sites and local health departments, and analyses of qualitative
interviews culled from three visits to each site (28). Clinic/provider-level factors included
clinic characteristics, person providing linkage to care, data-sharing/OW function, and
assessment of OW effectiveness. OW effectiveness was derived from site visits and staff
interviews and based on experience, integration within the clinical site, subjective
relationship with the health department and other partners, and reported relationships with
clients. These assessments were coded as higher and lower effectiveness.
Clinic characteristics assessed potential ‘adolescent-friendliness’ and were coded based on
the population served in the specific clinic space (adolescent only, shared adolescent/
pediatrics, specialty HIV care only [including adolescent and adult patients], and shared
pediatric/adolescent check-in but separate clinic space).(29) The person providing LTC was
coded as the AMTU OW, other AMTU staff, or non-AMTU staff. A variable capturing each
site's data sharing and OW function was based on two site-specific characteristics: how the
AMTU OW interacted with clients, and whether local health authorities granted PHA. In
most (14/15) AMTU, the OW directly interacted with youth. In the remaining site, the OW
coordinated and verified linkage but had no patient interaction. PHA was based in 45 CFR §
164.512(b)(1)(i) (The Privacy Rule) which permits public health authorities to act in
collaboration with other entities in sharing of personal health information for the purposes of
preventing or controlling a disease.(30) , PHA was coded as absent or present based on
memoranda of understanding: 8 AMTU sites received PHA and 7 did not. Sites were denied
PHA for a variety of reasons (e.g., health departments’ privacy concerns, provision
conflicting directly with state law). Some sites obtained PHA but received data in aggregate
rather than client level.
Taken together, three data sharing and OW function models were identified:(27) Model A –
real time data shared with OWs working directly with patients (2 AMTU sites); Model B –
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real time data shared with OWs not interacting with patients (1 AMTU site); and, Model C –
aggregate data used by OWs directly interacting with patients (12 AMTU sites).
Outcome measures
The two outcome variables were linkage to care and engagement in care. Linkage was
defined as an HIV-related medical visit within 42 days of referral. Engagement was defined
as a second HIV-related medical visit within 16 weeks of initial visit. Other studies define
linkage as attending an appointment within 30 days of HIV-diagnosis (31) and engagement
as a second HIV-related visit within 3-4 months after an initial visit. (11, 13, 32). Some
research defines engagement as a broader process that includes both linkage and retention in
care. (33) The goal of this study is to better understand the explicit factors that influence
multiple steps in the care continuum. As such, we chose to differentiate between linkage and
engagement.
Statistical methods
The analysis used basic frequencies and chi-square tests, as well as generalized linear
models (PROC GENMOD). GENMOD was used to run logistic regression analysis (using a
logit link function) to reflect clustering within sites. Models were explored through a
stepwise process, where significant predictors were added individually, and checked for
collinearity and interactions; only significant (p < 0.05) terms were retained in final models.
During exploratory data analysis, missing data for various risk variables were found to be
strongly associated with LTC. Thus, GENMOD was used for LTC (for cases with complete
data) and to model predictive factors for missing data. The analysis adjusted for confounders
by including them in these models. All data analysis was run in SAS Version 9.2.
RESULTS
By 32 months into the program, 2076 youth were referred, of which 80.9% (1679/2076)
were eligible for linkage (Table I). The remainder (19.1% [397/2076]), were ineligible due
to being outside a site's jurisdiction (n=61) or already linked (n=336). A total of 1172/1679
(69.8%) were linked. LTC rates ranged from 52%-89% among sites. Reasons for linkage
failure (N=507/1679; 30.2%) included insufficient contact information (52/507; 10.3%),
inability to locate (144/507; 28.4%), refused LTC services (53/507; 10.5%), failed
appointments (211/507; 41.6%), and other (47/506; 9.3%) (data not shown).
Among youth linked to care, 1043/1172 (89.0%) were subsequently engaged. Engagement
rates ranged from 71%-100% across sites. Overall, 62.1% (1043/1679) of eligible
adolescents were ultimately linked and engaged (Figure 1). Successful HIV care linkage and
engagement was reported for less than two-thirds of adolescents in eight sites (Table I).
Success was not simply a matter of referral volume, as the site with lowest number of
referrals (Site O) and the site with the most referrals (Site L) both linked and engaged two-
thirds or more of referred patients.
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Factors associated with linkage to care
Of eligible referred youth, 78.4% were male, median age was 21 years, and 68.4% reported
race-ethnicity as non-Hispanic black. The most common mode of transmission was male-to-
male sexual contact (63.6%). Client-level factors potentially associated with LTC are shown
in Table II. Proportionally fewer males (68.8%) were linked than females (76.5%). The
proportion of youth linked was greater among 15-17 year olds (78.7%) than 22-24 year olds
(69.8%). Linkage among Hispanic youth (70.9%) and those indicating “other” race/ethnicity
(44.2%) was lower than non-Hispanic whites (81.3%). Persons with “missing” sexual
identities had a lower rate of linkage (36%) than persons with heterosexual identities
(75.1%). Rates of linkage were similar for all modes of HIV acquisition except “other”,
which had much lower rates (32.0%). Persons with housing had a significantly higher rate of
linkage than those who were homeless. The absence of history of syphilis was associated
with higher rates of linkage than those with syphilis history; however, “unknown” syphilis
history had a significantly lower rate of linkage (81.8%, vs. 73.4% and 41.8% respectively).
Missing client demographic and behavioral data were important indicators of linkage failure.
In some instances (e.g., age), the percentage of missing data was small but still associated
with decreased likelihood of linkage. For other characteristics (e.g. education level), the
proportion of missing data was 32.9%, of which only 41% were LTC. When missing data
was reported as “unknown” for all categories except drug use, linkage rates were
significantly lower than for clients for whom those data were available (Table II).
Linkage rates were similar by geographic region, though the Midwest had significantly
higher rates than the South (Table III). Model A had significantly higher LTC rates than
Model B. Sites judged to have lower OW effectiveness had higher linkage rates (OR = 1.34,
95% CI 1.09 to 1.66). The rate of successful linkage for cases assigned to the OW (75.1%)
were significantly higher than those assigned to non-AMTU personnel (52.9%).
In multivariable, mixed effects models (Table IV), LTC rates were significantly higher for
Midwest sites and lower in Puerto Rico as compared with the South, higher in adolescent-
only clinics than HIV-only or shared, and higher when AMTU OWs were assigned to the
case as compared to other AMTU staff. No other demographic or provider characteristics,
including OW effectiveness, were associated with significant differences in linkage.
Factors associated with engagement in care
Only two demographic characteristics – age and education – were significantly associated
with engagement (Table II). In each case, missing data were associated with a lower rate of
successful engagement. Engagement was 63.6% for those whose age was missing compared
with 86.9% for 22-24 year olds. Engagement was 78.6% for those missing education data
compared to 91.7% for those with college or above.
Sites in clinic engagement Models B and C had significantly lower rates of engagement than
those in Model A (real time data shared with OWs working directly with patients) (Table
III). Clinics serving adolescent and pediatric patients and those that focused on HIV only
were more successful in engaging adolescents than those that were adolescent only (see
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Table III). OWs judged to be of lower effectiveness were also associated with lower rates of
engagement (86.1%) compared to those with higher effectiveness (91.7%).
In multivariable mixed effects models, data sharing model and OW effectiveness were both
significantly associated with engagement. Both Models B and C had significantly lower
rates of engagement than Model A. Sites with lower OW effectiveness had significantly
lower rates of engagement than those with higher effectiveness (Table IV). Other
demographic and clinic/provider variables considered were not significant in the final
adjusted model (see Tables II and III for all variables).
Factors associated with missing data
To additionally explore issues related to missing data, five key client demographic variables
with high rates of missing data were selected: housing status, insurance status, STD history,
substance use, and risk behaviors. 47% of study subjects were missing one or more of these
items. The percent of subjects with missing data for these items varied substantially between
sites (p < 0.0001), from 19% to 90%, with a median of 72% and IQR of 43% to 61% (data
not shown).
A mixed effects model using generalized estimating equations was used to control for
multiple subjects within site (Table V). Five clinic/provider characteristics (region of clinic,
data sharing model, clinic characteristics, functional PHA status, and provider assigned to
linkage) were included to assess potential variation in regional policies related to HIV
testing and linkage. Sites in the Midwest and Puerto Rico were significantly less likely to
have missing data, and sites in the West were significantly more likely to have missing data,
compared to sites in the South. Clinics that served only HIV patients had less missing data
than adolescent only clinics. Cases handled by other AMTU staff had significantly more
missing data than those handled by the OW. Other demographic and clinic/provider
variables considered were not significant in the final adjusted model (see Tables II and III
for all variables).
DISCUSSION
Only 62% of HIV-positive adolescents and young adults were both linked to, and engaged
in, care during the first six months following diagnosis. Thus, more than one-third of newly
diagnosed youth do not receive the full benefits of intensive early medical treatment. This
conflicts with the National HIV/AIDS Strategy goals of “seamless” linkage to care. (26)
Moreover, opportunities for post-diagnosis transmission prevention – including reduction of
viral load – are lost for the not-in-care youth. Because case-management models are the
standard for HIV linkage, our research provided support for full-time OWs to facilitate the
linkage and engagement process. An important lesson of this research is that even with this
level of personal support, linkage and engagement rates varied substantially among sites,
suggesting that additional factors influence care engagement.
One local structural factor affecting linkage and engagement is the quality of collaboration
between local health departments and HIV treatment sites. By requiring formal memoranda
of understanding between AMTUs and local health departments – specifically around formal
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PHA – the authors of the study protocol hoped to better understand local structural
facilitators to linkage and engagement. This is important due to studies showing that health
departments and community organizations can respond to the introduction of HIV-related
services with indifference or even active resistance. (34-36) In multivariable models, linkage
and engagement rates were higher at sites where PHA allowed OWs to directly interact with
newly diagnosed youth. These data suggest that HIV-related care within communities can be
improved by close collaborations within communities between public health systems and
HIV-treatment systems. (9, 34)
We found differences in factors associated with HIV care linkage and engagement. Linkage
depends on both client-level characteristics (i.e., gender, race/ethnicity, and housing) and
clinic/provider factors (i.e., public health authority and OW qualifications). High quality
data sharing is critical, as shown by the substantial reductions in care linkage when key data
were missing. Thus, local structural factors such as relationships between diagnostic and
treatment facilities may substantially affect linkage. Engagement, by contrast, is largely
associated with clinic and provider characteristics. Well-trained personnel and quality care
infrastructure can influence longer-term care engagement.
This research demonstrates several of the key elements of best practices models that can
facilitate the coordination of community-wide HIV testing and treatment. Failure of linkage
and engagement are key attrition sources in the ‘HIV/AIDS care continuum’ between HIV
diagnosis and achieving an undetectable viral load.(37) Improved understanding of linkage
and engagement can inform approaches to a population-wide implementation of an “HIV
treatment as prevention” philosophy. (38) In particular, adolescents may require carefully
integrated, community-wide services to fully realize the benefits of contemporary HIV-
related care.
Our study represents a large and comprehensive data set for care linkage and engagement
among HIV-positive adolescents. However, HIV testing within communities is neither
systematic nor coordinated, and data from mandated reporting often lags the need for
linkage by several months. Referral bias is also possible: a small proportion (about 16%) of
youth was already linked at the time of referral; these individuals were, however, excluded
from analysis. Our study presents an exploratory analysis with many descriptive statistics;
because of the exploratory nature, we have not adjusted for multiple comparisons and care
should be taken when drawing conclusions. Additionally, the limited number of sites in
Models A and B limits our ability to generalize conclusions drawn from these data.
An additional issue relates to missing data and its importance in the ultimate success of care
linkage and engagement. Sensitive items in our study, such as history of STIs, drug use, or
sexual risk behaviors, were subject to extensive missing data; respondents with such missing
data were much less likely to be linked to care. While the missing data makes it difficult to
assess relationships between sensitive items and linkage, the more important result may be
that persons unwilling to report these data were less willing to follow up on treatment. Our
study was designed to optimize health information sharing to facilitate care. However, HIV
remains an intensely stigmatized condition, and appropriate privacy safeguards exist in
tension with the necessary activation of appropriate supports for treatment. Systematic
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efforts to improve HIV-related care will continue to involve social, policy, and practice-
related efforts to provide high-quality health information sharing across the various systems
involved in HIV testing and treatment, while maintaining high standards of privacy for
persons living with HIV.
CONCLUSIONS
These study findings show that linkage is most affected by client and clinic-level factors
while engagement is most influenced by clinic and provider-level factors, thus highlighting
the importance of taking a comprehensive approach to increase adolescents’ linkage and
engagement rates. HIV care linkage and engagement are complex processes best addressed
through coordinated local and national efforts. Locally, improved information transfer and
identification of structural barriers to linkage and engagement are needed. Nationally,
models for best practices, and implementation of these models could facilitate improvements
in how youth enter HIV care for their lifetime. Only through addressing individual- and
structural-level barriers to care linkage and engagement will we be able to fully realize the
goals of the National HIV/AIDS Strategy.(26)
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Figure 1.
The number of adolescents that were eligible for linkage, linked, and engaged in care.
1
 Missing data did not necessarily eliminate individuals from being counted within each
level (as it was often individual variables that were missing, not complete data).
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